Publications for Henrik Green
Co-author map based on ISI articles 2007-

Publications mentioned in social media 12 times*

Keywords

variants treatment toxicity survival snps polymorphisms phosphorylation patients paclitaxel ovarian model leukemia imatinib h1 gene drug cells canertinib cancer abcb1

Journal Articles

Johanna Hasmats, Henrik Green, Cedric Orear, Pierre Validire, Mikael Huss, Max Kaller and Joakim Lundeberg
  Assessment of Whole Genome Amplification for Sequence Capture and Massively Parallel Sequencing
  PLoS ONE, 2014, 9(1), 84785.
   Fulltext  PDF  

Karin Skoglund, Samuel Boiso, Jan-Ingvar Jönsson, Svante Vikingsson, Björn Carlsson and Henrik Green
  Single-nucleotide polymorphisms of ABCG2 increase the efficacy of tyrosine kinase inhibitors in the K562 chronic myeloid leukemia cell line
 
Altmetric usage: 1

  Pharmacogenetics & Genomics, 2014, 24(1), 52-61.
   Fulltext  PDF  

Ingrid Jakobsen Falk, Anna Fyrberg, Esbjörn Paul, Hareth Nahi, Monica Hermanson, Richard Rosenquist, Martin Höglund, Lars Palmqvist, Dick Stockelberg, Yuan Wei, Henrik Gréen and Kourosh Lotfi
  Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidase
  American Journal of Hematology, 2013, 88(12), 1001-1006.

Luis J. Leandro-Garcia, Lucia Inglada-Perez, Guillermo Pita, Elisabet Hjerpe, Susanna Leskelae, Carlos Jara, Xabier Mielgo, Anna Gonzalez-Neira, Mercedes Robledo, Elisabeth Avall-Lundqvist, Henrik Green and Cristina Rodriguez-Antona
  Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy
  Journal of Medical Genetics, 2013, 50(9), 599-605.
 Web of Science® Times Cited: 1

Karin Skoglund, Samuel Boiso Moreno, Maria Baytar, Jan-Ingvar Jönsson and Henrik Gréen
  ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro
 
Altmetric usage: 4

  Pharmacogenomics and Personalized Medicine, 2013, 6, 63-72.
   Fulltext  PDF  

Samuel Boiso, Anna Lena Zackrisson, Ingrid Jakobsen Falk, Louise Karlsson, Björn Carlsson, Andreas Tillmar, Fredrik Kugelberg, Johan Ahlner, Staffan Hägg and Henrik Green
  ABCB1 gene polymorphisms are associated with suicide in forensic autopsies
 
Altmetric usage: 1

  Pharmacogenetics & Genomics, 2013, 23(9), 463-469.

Louise Karlsson, Henrik Green, Anna Lena Zackrisson, Finn Bengtsson, I Jakobsen Falk, Björn Carlsson, Johan Ahlner and Fredrik Kugelberg
  ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram
  International journal of legal medicine (Print), 2013, 127(3), 579-586.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Troels K Bergmann, Werner Vach, Soren Feddersen, Lise Eckhoff, Henrik Green, Jorn Herrstedt and Kim Brosen
  Letter: GWAS-based association between RWDD3 and TECTA variants and paclitaxel induced neuropathy could not be confirmed in Scandinavian ovarian cancer patients
  Acta Oncologica, 2013, 52(4), 871-U231.
 Web of Science® Times Cited: 1

Liza Ljungberg, Karin Persson, Andreas Eriksson, Henrik Green and Per Whiss
  Effects of nicotine, its metabolites and tobacco extracts on human platelet function in vitro
  Toxicology in Vitro, 2013, 27(2), 932-938.
   Fulltext  PDF  

Martin N Fransson, Jan Brugard, Peter Aronsson and Henrik Green
  Semi-physiologically based pharmacokinetic modeling of paclitaxel metabolism and in silico-based study of the dynamic sensitivities in pathway kinetics
  European Journal of Pharmaceutical Sciences, 2012, 47(4), 759-767.
   Fulltext  PDF  

Johanna Hasmats, Henrik Green, Beata Werne Solnestam, Pawel Zajac, Mikael Huss, Cedric Orear, Pierre Validire, Magnus Bjursell and Joakim Lundeberg
  Validation of whole genome amplification for analysis of the p53 tumor suppressor gene in limited amounts of tumor samples.
  Biochemical and Biophysical Research Communications - BBRC, 2012, 425(2), 379-83.

Tove Sivik, Svante Vikingsson, Henrik Gréen and Agneta Jansson
  Expression Patterns of 17β-Hydroxysteroid Dehydrogenase 14 in Human Tissues
  Hormone and Metabolic Research, 2012, 44(13), 949-956.
   Fulltext  PDF  

Johanna Hasmats, Ilya Kupershmidt, Cristina Rodriguez-Antona, Qiaojuan Jane Su, Muhammad Suleman Khan, Carlos Jara, Xabier Mielgo, Joakim Lundeberg and Henrik Green
  Identification of candidate SNPs for drug induced toxicity from differentially expressed genes in associated tissues
 
Altmetric usage: 2

  Gene, 2012, 506(1), 62-68.
 Web of Science® Times Cited: 2

Luis J Leandro-Garcia, Susanna Leskelae, Carlos Jara, Henrik Green, Elisabeth Avall-Lundqvist, Heather E Wheeler, M Eileen Dolan, Lucia Inglada-Perez, Agnieszka Maliszewska, Aguirre A de Cubas, Inaki Comino-Mendez, Veronika Mancikova, Alberto Cascon, Mercedes Robledo and Cristina Rodriguez-Antona
  Regulatory Polymorphisms in beta-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy
 
Altmetric usage: 1

  Clinical Cancer Research, 2012, 18(16), 4441-4448.
 Web of Science® Times Cited: 14

Henrik Green, Ingrid Jakobsen Falk, Kourosh Lotfi, E Paul, M Hermansson, R Rosenquist, C Paul and H Nahi
  Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype
  The Pharmacogenomics Journal, 2012, 12(2), 111-118.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Troels K Bergmann, Charlotte Brasch-Andersen, Henrik Green, Mansoor R Mirza, Kristin Skougaard, Jessica Wihl, Nina Keldsen, Per Damkier, Curt Peterson, Werner Vach and Kim Brosen
  Impact of ABCB1 Variants on Neutrophil Depression: A Pharmacogenomic Study of Paclitaxel in 92 Women with Ovarian Cancer
 
Altmetric usage: 3

  Basic & Clinical Pharmacology & Toxicology, 2012, 110(2), 199-204.
 Web of Science® Times Cited: 2

Ingrid Jakobsen Falk, Muhammad Suleman Khan, Lena Thunell, Hareth Nahi and Henrik Green
  Association of CYP2B6 Genotype with Survival and Progression Free Survival in Cyclophosphamide Treated Multiple Myeloma
  Journal of Cancer Therapy, 2012, 3(1), 20-27.
   Fulltext  PDF  

Emelie Djerf, Cecilia Trinks, Henrik Green, Avni Abdiu, Anna-Lotta Hallbeck, Olle Stål and Thomas Walz
  The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo
  Biochemical and Biophysical Research Communications - BBRC, 2011, 414(3), 563-568.
 Web of Science® Times Cited: 2

Henrik Green, Olle Stål, K Bachmeier, L M Bäcklund, L Carlsson, J Hansen, M Lagerlund, B Norberg, A Franzén, A Åleskog and Annika Malmström
  Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified
  Cancer Letters, 2011, 313(2), 145-153.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Mette M H Christensen, Charlotte Brasch-Andersen, Henrik Green, Flemming Nielsen, Per Damkier, Henning Beck-Nielsen and Kim Brosen
  The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
  Pharmacogenetics & Genomics, 2011, 21(12), 837-850.
 Web of Science® Times Cited: 27

Amanda Nordigården, Jenny Zetterblad, Cecilia Trinks, Henrik Green, Pernilla Eliasson, Pia Druid, Kourosh Lotfi, Lars Ronnstrand, Thomas Walz and Jan-Ingvar Jönsson
  Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice
  British Journal of Haematology, 2011, 155(2), 198-208.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Henrik Green, Muhammad Suleman Khan, Ingrid Jakobsen Falk, Elisabeth Avall-Lundqvist and Curt Peterson
  Impact of CYP3A5(*)3 and CYP2C8-HapC on Paclitaxel/Carboplatin-Induced Myelosuppression in Patients with Ovarian Cancer
  Journal of Pharmaceutical Sciences, 2011, 100(10), 4205-4209.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Anna Gréen, Bettina Sarg, Henrik Green, Anita Lönn, Herbert H Lindner and Ingemar Rundquist
  Histone H1 interphase phosphorylation becomes largely established in G(1) or early S phase and differs in G(1) between T-lymphoblastoid cells and normal T cells
  EPIGENETICS and CHROMATIN, 2011, 4(15), .
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Cecilia Trinks, Emelie A. Severinsson, Birgitta Holmlund, Anna Gréen, Henrik Green, Jan-Ingvar Jönsson, Anna-Lotta Hallbeck and Thomas Walz
  The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells
  Biochemical and Biophysical Research Communications - BBRC, 2011, 410(3), 422-427.
 Web of Science® Times Cited: 1

Troels K. Bergmann, Henrik Green, Charlotte Brasch-Andersen, Mansoor R. Mirza, Jorn Herrstedt, Berit Holund, Andreas du Bois, Per Damkier, Werner Vach, Kim Brosen and Curt Peterson
  Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer
  European Journal of Clinical Pharmacology, 2011, 67(7), 693-700.
 Web of Science® Times Cited: 21

Cristina Rodríguez-Antona and Henrik Gréen
  Editorial: Microtubule-targeting drugs and personalization of cancer treatment.
  Pharmacogenomics (London), 2011, 12(4), 449-51.

T K Bergmann, C Brasch-Andersen, Henrik Green, M Mirza, R S Pedersen, F Nielsen, K Skougaard, J Wihl, N Keldsen, P Damkier, L E Friberg, Curt Peterson, W Vach, M O Karlsson and K Brosen
  Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer
  PHARMACOGENOMICS JOURNAL, 2011, 11(2), 113-120.
   Fulltext  PDF  
 Web of Science® Times Cited: 30

Martin N Fransson, Henrik Green, Jan-Eric Litton and Lena E Friberg
  Influence of Cremophor EL and Genetic Polymorphisms on the Pharmacokinetics of Paclitaxel and Its Metabolites Using a Mechanism-Based Model
  DRUG METABOLISM AND DISPOSITION, 2011, 39(2), 247-255.
 Web of Science® Times Cited: 10

Tove Sivik, Svante Vikingsson, Henrik Greén and Agneta Jansson
  A validated and rapid high-performance liquidchromatography method for the quantification ofconversion of radio-labelled sex steroids
  Hormone Molecular Biology and Clinical Investigation, 2010, 3(1), 375-381.

Henrik Green, Karin Skoglund, Franz Rommel, Rajaa A Mirghani and Kourosh Lotfi
  CYP3A activity influences imatinib response in patients with chronic myeloid leukemia: a pilot study on in vivo CYP3A activity
  EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66(4), 383-386.
   Fulltext  PDF  
 Web of Science® Times Cited: 18

Henrik Green, Peter Söderkvist, Per Rosenberg, Rajaa A Mirghani, Per Rymark, Elisabeth Avall Lundqvist and Curt Peterson
  Pharmacogenetic Studies of Paclitaxel in the Treatment of Ovarian Cancer
  Basic and clinical pharmacology and toxicology, 2009, 104(2), 130-137.
   Fulltext  PDF  
 Web of Science® Times Cited: 42

Henrik Green
  Pharmacogenomics of importance for paclitaxel chemotherapy
  Pharmacogenomics (London), 2008, 9(6), 671-674.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Henrik Green, Peter Söderkvist, Per Rosenberg, Grörgy Horvath and Curt Peterson
  ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel
  Journal of Pharmaceutical Sciences, 2008, 97(6), 2045-2048.
   Fulltext  PDF  
 Web of Science® Times Cited: 28

Martin Fransson and Henrik Gréen
  Comparison of two types of population pharmacokinetic model structures of paclitaxel
  European Journal of Pharmaceutical Sciences, 2008, 33(2), 128-137.
 Web of Science® Times Cited: 3

Henrik Green, Peter Söderkvist, Per Rosenberg, Rajaa A. Mirghani, Per Rymark, Elisabeth Åvall-Lundqvist and Curt Peterson
  Pharmacogenetics of Paclitaxel in the Treatment of Ovarian Cancer – a Pilot Study in Preparation of Individualized Chemotherapy
  Clinical Cancer Research, 2007, , .

Henrik Green, Peter Söderkvist, Per Rosenberg, Horvath György and Curt Peterson
  Letters to the Editor: ABCB1 2677>T/A Genotype and paclitaxel pharmacogenetics in ovarian cancer - Response
  Clinical Cancer Research, 2006, 12(13), 4127-4129.
 Web of Science® Times Cited: 2

Henrik Green, Karin Vretenbrant (Öberg), Björn Norlander and Curt Peterson
  Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography/ion trap mass spectrometry with a sonic spray ionization interface
  Rapid Communications in Mass Spectrometry, 2006, 20(14), 2183-2189.
   Fulltext  PDF  
 Web of Science® Times Cited: 15

Henrik Green, Peter Söderkvist, Per Rosenberg, György Horvath and Curt Peterson
  mdr-1 single nucleotide polymorphisms in ovarian cancer tissue – G2677T/A correlates with response to paclitaxel chemotherapy
  Clinical Cancer Research, 2006, 12(3 pt 1), 854-859.
   Fulltext  PDF  
 Web of Science® Times Cited: 92

Henrik Green, Per Rosenberg, Peter Söderkvist, György Horvath and Curt Peterson
  β-tubulin mutations in ovarian cancer using single strand conformation analysis – risk of false positive results from paraffin embedded tissues
  Cancer Letters, 2006, 236(1), 148-154.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Henrik Green, Kourosh Lotfi, Anna Lena Zackrisson and Curt Peterson
  Spontaneous Reversal of P-Glycoprotein Expression in Multidrug Resistant Cell Lines
  Pharmacology and Toxicology, 2003, 93(6), 297-304.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Samuel Svensson, Sofi Lindgren, Wendy Powell and Henrik Green
  Melanin inhibits cytotoxic effects of doxorubicin and daunorubicin in MOLT 4 cells
  Pigment Cell Research, 2003, 16(4), 351-354.
 Web of Science® Times Cited: 10

Conference Articles

Karin Skoglund, Samuel Boiso Moreno, Jan-Ingvar Jönsson and Henrik Green
  Functional Characterization of ABCG2 Polymorphisms and Their Influence on Tyrosine Kinase Inhibitor Effects in Chronic Myeloid Leukemia Cells in BLOOD, vol 118, issue 21, pp 1491-1491
  BLOOD, 2011.


Christer Paul, Henrik Green, Ingrid Jakobsen Falk, Kourosh Lotfi, Esbjorn Paul, Monika Hermansson, Richard Rosenquist, Kerstin Jonsson-Videsater and Hareth Nahi
  Implications On Drug Resistance and Survival of ABCB1 Single Nucleotide Polymorphisms in Normal Karyotype De Novo AML in BLOOD, vol 114, issue 22, pp 1038-1039
  BLOOD, 2009.


T K Bergmann, Henrik Green, M O Karlsson, L Friberg, F Nielsen, C Brasch-Andersen and K Brosen
  Impact of sequence variants in CYP2C8 on paclitaxel clearance in ovarian cancer patients in EJC SUPPLEMENTS, vol 7, issue 2, pp 92-92
  EJC SUPPLEMENTS, 2009.


E. Paul, Kourosh Lotfi, I. Jakobsen Falk, R. Rosenquist, C. Paul, H. Nahi and Henrik Green
  ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS IN DE NOVO AML WITH NORMAL KARYOTYPE - IMPLICATIONS ON DRUG RESISTANCE AND SURVIVAL
  in HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, vol 94, 2009.


Henrik Gréen, Karin Vretenbrandt, Björn Norlander and Curt Peterson
  Measurement of Paclitaxel and its metabolites in Human Plasma Using a Liquid Chromatography - Ion Trap Mass Spectrometer with a SSI interface
  Mass Spectrometry of Small Molecular Drugs, 2008.


Peter Fritzson, Erik Ulfhielm, Ales Belic, Martin Fransson and Henrik Green
  Biochemical Mathematical Modeling with Modelica and the BioChem Library
  Aplimat 2007,2007, 2007.


Henrik Green, Karin Skoglund, Franz Rommel, Leif Bertilsson and Kourosh Lotfi
  Influence of CYP3A4 activity on imatinib response in paitents with chronic myeloid leukemia
  11th congress of the European Heamtology Association,2006, 2006.


Henrik Gréen, Cecilia Runnqvist, Julia Bak, Peter Söderqvist, Per Rosenberg and Curt Peterson
  Strategies for individualization of Taxol (paclitaxel) treatment of ovarian cancer
  Proceedings of the American Association for Cancer Research,2002, 2002.


Wendy Powell, Henrik Green and Samuel Svensson
  A new method for screening the melanin binding ability of different antineoplastic agents.
  Pigment cell research,2001, 2001.


Henrik Gréen, Malin Lindqvist Appell, Anna Lena Zackrisson, Gunnar Juliusson and Curt Peterson
  P-gp and mdr-1 mRNA in leukemic cells fromAML patients during chemotheraphy.
  Proceedings of the American Association for Cancer Research,2001, 2001.


Ph.D. Theses

Karin Skoglund
  Influence of CYP3A enzymes and ABC transporters on the activity of tyrosine kinase inhibitors in chronic myeloid leukemia
  2013.


  Fulltext PDF

Henrik Green
  Pharmacogenetic Studies of Paclitaxel in Ovarian Cancer: focus on interindividual differences in pharmacodynamics and pharmacokinetics
  2007.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.